{"id":"W3169994009","doi":"10.1200/jco.2021.39.15_suppl.9574","title":"Association of health-related quality of life (HRQoL) and treatment safety with nivolumab (NIVO) in patients (pts) with resected stage IIIB/C or IV melanoma: Analysis of CheckMate 238 four-year follow-up (FU) data.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Nivolumab; Discontinuation; Internal medicine; Randomization; Quality of life (healthcare); Population; Ipilimumab; Adverse effect; Oncology; Randomized controlled trial; Cancer; Immunotherapy; Nursing","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001407819,0.0001830636,0.0005351061,0.0002826096,0.0001340363,0.0003969856,0.0002379643,0.0002950207,0.00102107],"category_scores_gemma":[0.001512984,0.0001277764,0.000826566,0.0003200998,0.0002102809,0.0002839527,0.0002477192,0.0004712541,0.0001139383],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003594364,"about_ca_system_score_gemma":0.0002293291,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005766585,"about_ca_topic_score_gemma":0.000989848,"domain_scores_codex":[0.9995021,0.0002342116,0.00004248559,0.00008503981,0.00007471687,0.00006141355],"domain_scores_gemma":[0.9985737,0.000469759,0.000625108,0.00008216564,0.00005394951,0.0001954579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08643839,0.001619586,0.8779668,0.000205591,0.002762893,0.0001006077,0.00009037507,0.001084484,0.004721152,0.00003784747,0.0004874725,0.02448481],"study_design_scores_gemma":[0.002735266,0.01650565,0.97697,0.00001395975,0.0007783761,0.0001709727,0.00003853934,0.001427028,0.0007877666,0.00003810393,0.0005206819,0.000013691],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994162,0.0002739174,0.00003393383,0.00001230121,0.000002420976,0.00001408313,0.0001759297,0.000001343214,0.00006997172],"genre_scores_gemma":[0.9993436,0.00006948818,0.00005574573,0.0000210224,0.000008385092,0.00002112782,0.000402944,7.650103e-7,0.00007700897],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001407819,"threshold_uncertainty_score":0.007445335,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1540362687130948,"score_gpt":0.4370518829146876,"score_spread":0.2830156142015928,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}